Regulus Therapeutics Inc.
NASDAQ: RGLS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joseph P. Hagan
- Employees
- 34
- Headquarters
- San Diego, United States
- IPO year
- 2012
- Market cap
- $565.0M
- Website
- https://www.regulusrx.com
Loading RGLS…
Loading profile data…Frequently asked questions about RGLS
What does Regulus Therapeutics Inc. (RGLS) do?
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compou...
Where does RGLS trade?
Regulus Therapeutics Inc. (RGLS) trades on the NASDAQ Capital Market.
What sector is RGLS in?
Regulus Therapeutics Inc. (RGLS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Regulus Therapeutics Inc.?
Joseph P. Hagan is the chief executive officer of Regulus Therapeutics Inc. (RGLS).
Where is Regulus Therapeutics Inc. headquartered?
Regulus Therapeutics Inc. is headquartered in United States.
Does RGLS pay a dividend?
Regulus Therapeutics Inc. (RGLS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RGLS go public?
Regulus Therapeutics Inc. (RGLS) completed its initial public offering in 2012.